-transparent.png){kind=logo}
Blood cell isozymes, red cell antigens, immunoglobulin allotypes, and marker chromosomes are suitable tools to monitor bone marrow engraftment and marrow graft quality. Data on genetic markers from 26 patients who underwent bone marrow transplantation as a treatment for acute leukemia are presented here.
Related Publications
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
October 1977,
Vox sanguinis,
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
January 1976,
Hereditas,
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
December 1958,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
March 1959,
Project report. USAF School of Aviation Medicine,
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
February 1986,
Cancer genetics and cytogenetics,
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
April 1988,
Lancet (London, England),
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
September 1989,
Anales espanoles de pediatria,
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
January 1989,
Disease markers,
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
March 1972,
The Medical clinics of North America,
K G Blume, and
E Beutler, and
K J Bross, and
G M Schmidt, and
W E Spruce, and
R L Teplitz
April 1990,
European journal of clinical investigation,
